Findex Inc 2025 AR2
The report highlights Findex Inc.'s financial and operational performance for the fiscal year 2025, during which the company achieved consolidated net sales of JPY 6,109,941 thousand. The company advanced its sustainability initiatives, aligning with TCFD recommendations and participating in the Carbon Disclosure Project (CDP). Findex was recognized as an 'Enterprise Certified for Entrustment with Handling Medical and Other Data' under the Next Generation Medical Infrastructure Act, establishing its new Medical Data Platform Business. Additionally, the company was included in the 'World's Best Companies in Sustainable Growth 2026' by TIME Magazine and Statista.
Company: Findex Inc
Sector: Health Care
Country: Japan
Year: 2025
Type: AR2
Pages: 87
Findex Inc
Annual Securities Report
The report highlights Findex Inc.'s financial and operational performance for the fiscal year 2025, during which the company achieved consolidated net sales of JPY 6,109,941 thousand. The company advanced its sustainability initiatives, aligning with TCFD recommendations and participating in the Carbon Disclosure Project (CDP). Findex was recognized as an 'Enterprise Certified for Entrustment with Handling Medical and Other Data' under the Next Generation Medical Infrastructure Act, establishing its new Medical Data Platform Business. Additionally, the company was included in the 'World's Best Companies in Sustainable Growth 2026' by TIME Magazine and Statista.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees